Life Briefing: How Does Cost Affect Access to Health Care? Strategic angle: This analysis explores trends in how the cost of healthcare affects access to care in the U.S. editorial-staff Mar 10
Life Briefing: GOP Senator Investigates FDA Over Rare Disease Drug Rejections Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary. editorial-staff Mar 10
Life Briefing: What’s next for RFK Jr.’s MAHA allies on vaccine policy? Strategic angle: A coalition of Kennedy's allies gathered to discuss vaccines, but the health secretary was rarely mentioned. editorial-staff Mar 10
Life BioNTech Founders to Depart, Form New mRNA-Focused Company Ugur Sahin and Özlem Türeci, the couple who co-founded BioNTech, are leaving the Covid-19 vaccine maker to start a new, mRNA-focused firm. editorial-staff Mar 10
Life Briefing: Health AI startup to benefit from $1 billion funding round for Yann LeCun’s AMI Strategic angle: AI scribe company Nabla aims to be much more by using tech from Yann LeCun's new startup AMI, which just raised $1 billion. editorial-staff Mar 10
Life Briefing: U.S. Senator Probes FDA Amid BioNTech Founders' Departure Strategic angle: The co-founders of BioNTech, known for their Covid-19 vaccine, are set to leave the company to launch a new mRNA-focused venture. editorial-staff Mar 10
Life Briefing: Amid dueling autism meetings, HHS cancels Strategic angle: Epilepsy med response, a long-awaited fix to the kidney transplant system, and more health news editorial-staff Mar 10
Life Briefing: Oral Contraceptive Pills: Access and Availability Strategic angle: An overview of oral contraception, insurance coverage, and strategies to enhance access for women. editorial-staff Mar 10
Life Briefing: Large drugmakers are developing fewer antibiotics, analysis finds Strategic angle: The number of potential antimicrobial treatments being developed by the world’s largest drugmakers nosedived by 35% over the past five years, according to a new analysis. editorial-staff Mar 10
Life Briefing: Removing race from kidney function algorithm helped more Black patients access transplants Strategic angle: A significant change in the eGFR algorithm led to increased kidney transplant opportunities for Black patients. editorial-staff Mar 10
Life Briefing: Over-the-Counter Oral Contraceptive Pills Approved Strategic angle: FDA approves Opill, marking a significant change in access to oral contraceptives in the U.S. editorial-staff Mar 10
Life Briefing: Vertex says its drug successfully reduced marker of kidney disease in late-stage trial Strategic angle: Vertex reported that its drug, acquired for $4.9 billion, halved a key marker of IgA nephropathy in late-stage trials. editorial-staff Mar 9
Life Briefing: KFF Tracker: America First MOU Bilateral Global Health Agreements Strategic angle: This tracker provides up-to-date information on countries with signed bilateral MOU global health agreements with the U.S. editorial-staff Mar 9
Life Briefing: The ER Staffing Conflict and No Facility Fee for a Marmot Strategic angle: A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine. editorial-staff Mar 9
Life Briefing: Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State Strategic angle: Tracking the status of Section 1115 Medicaid waivers across states, highlighting approved and pending provisions. editorial-staff Mar 9
Life Briefing: A setback for Roche’s breast cancer drug Strategic angle: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news editorial-staff Mar 9
Life Briefing: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales Strategic angle: Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug. editorial-staff Mar 9
Life Briefing: Fresh turmoil at the FDA with Prasad’s exit Strategic angle: Prasad out again, generic Ozempic on its way, and more health news from Morning Rounds editorial-staff Mar 9
Life Briefing: Lack of FDA Advisory Committees Raises Concerns Strategic angle: Growing worries about the FDA's diminishing use of advisory committees for public discourse. editorial-staff Mar 9
Life Briefing: Talkspace to be acquired for $835 million by mental health services giant Strategic angle: Universal Health Services announces acquisition of virtual mental health company Talkspace. editorial-staff Mar 9